NCT04384146View on ClinicalTrials.gov

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 7, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Non-Small Cell Lung Cancer
Interventions
RADIATION

Cyclical Hypofractionated Palliative Radiation (Quad Shot)

3.7 Gy twice daily x 2 days for a total dose of 14.8 Gy per cycle. The next cycle will occur after a 21-28 day break.

BEHAVIORAL

EORTC QLQ-C30 questionnaire

at baseline, each cycle of Quad Shot, and at 3 weeks, 3 months and 6 months after last cycle of Quad Shot.

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester (All protocol activities), Harrison

11553

Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre

11725

Memorial Sloan Kettering Commack (All protocol activities), Commack

07920

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown

07645

Memorial Sloan Kettering Bergen (All protocol activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER